A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes.
Tran-Duy A. et al, (2020), Diabetes Care
Group Testing for SARS-CoV-2: Forward to the Past?
Pouwels KB. et al, (2020), PharmacoEconomics - Open
Accurately reflecting uncertainty when using patient-level simulation models to extrapolate clinical trial data
DAKIN H. et al, (2020), Medical Decision Making
Registered Reports: Time to Radically Rethink Peer Review in Health Economics
CLARKE P. et al, (2020), PharmacoEconomics - Open
Defining and measuring health poverty
Clarke P. and Erreygers G., (2020), Social Science and Medicine, 244
Exploring the Impact of Quality of Life on Survival: A Case Study in Total Knee Replacement Surgery
Tew M. et al, (2020), Medical Decision Making
Primary Prevention of Cardiovascular Disease in Minority Indigenous Populations: A Systematic Review
Merone L. et al, (2020), Heart Lung and Circulation
The Surgeon's Role in the Opioid Crisis: A Narrative Review and Call to Action.
Shadbolt C. et al, (2020), Front Surg, 7
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
Furler J. et al, (2020), The Lancet Diabetes and Endocrinology, 8, 17 - 26
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.
Kent S. et al, (2019), PharmacoEconomics
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.
Tew M. et al, (2019), Pharmacoeconomics, 37, 931 - 941
Transparency in Decision Modelling: What, Why, Who and How?
Sampson CJ. et al, (2019), Pharmacoeconomics
IMPACT OF COMORBID CONDITIONS ON HEALTH CARE EXPENDITURE AND WORK-RELATED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS USING THE MEDICAL EXPENDITURE PANEL SURVEY IN THE PERIOD 2006-2015
Vu MV. et al, (2019), VALUE IN HEALTH, 22, S376 - S376
MODELLING PROGRESSION OF RISK FACTORS IN PATIENTS WITH TYPE 1 DIABETES: TOWARDS THE MOST APPROPRIATE FUNCTIONAL FORMS FOR A SIMULATION MODEL OF LONG-TERM HEALTH OUTCOMES
Tran-Duy A. et al, (2019), VALUE IN HEALTH, 22, S157 - S157
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
Carvalho N. et al, (2019), International Journal for Equity in Health, 18
Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians.
Tran-Duy A. et al, (2019), Heart, lung & circulation
Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: A population-based cohort study
Ke C. et al, (2019), Annals of Internal Medicine, 170, 145 - 154